KMB
KMB
Kimberly-Clark CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.08B ▼ | $958M ▲ | $499M ▲ | 12.23% ▲ | $1.5 ▲ | $685M ▼ |
| Q3-2025 | $4.13B ▼ | $855M ▼ | $446M ▼ | 10.79% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.16B ▼ | $864M ▼ | $509M ▼ | 12.23% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B ▼ | $964M ▼ | $567M ▲ | 11.71% ▲ | $1.71 ▲ | $976M ▲ |
| Q4-2024 | $4.93B | $1.13B | $447M | 9.07% | $1.34 | $760M |
What's going well?
Net income and earnings per share both improved this quarter, mainly due to a much lower tax bill. The company remains profitable and revenue is steady.
What's concerning?
Operating income and margins are falling as costs rise faster than sales. The improvement in profit is mostly from lower taxes, not better business performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $688M ▲ | $17.23B ▲ | $15.57B ▲ | $1.5B ▲ |
| Q3-2025 | $617M ▼ | $16.89B ▲ | $15.42B ▲ | $1.33B ▲ |
| Q2-2025 | $634M ▲ | $16.77B ▲ | $15.37B ▲ | $1.27B ▲ |
| Q1-2025 | $563M ▼ | $16.3B ▼ | $15.08B ▼ | $1.1B ▲ |
| Q4-2024 | $1.02B | $16.55B | $15.57B | $840M |
What's financially strong about this company?
KMB has a long record of profits, a solid base of real assets, and is managing inventory and receivables well. Debt is mostly long-term, giving them time to manage repayments.
What are the financial risks or weaknesses?
Liquidity is tight, with current assets not covering near-term bills. The company is highly leveraged, with much more debt than equity, leaving little margin for error if business slows.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $510M ▲ | $972M ▲ | $-2.99B ▼ | $-141M ▼ | $71M ▲ | $575M ▼ |
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.18B ▲ | $-40M ▼ | $1.11B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M ▲ | $327M ▼ | $-119M ▲ | $-683M ▲ | $-458M ▼ | $123M ▼ |
| Q4-2024 | $452M | $817M | $-194M | $-686M | $-90M | $608M |
What's strong about this company's cash flow?
KMB consistently generates positive cash from its core business, with operating cash flow rising to $972 million. Dividends are well covered, and the company isn't dependent on outside funding.
What are the cash flow concerns?
Free cash flow dropped sharply from last quarter, partly due to less help from working capital and higher capital spending. The cash balance is only moderate, so big surprises could tighten things.
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Consumer Tissue | $1.60Bn ▲ | $1.50Bn ▼ | $1.54Bn ▲ | $1.52Bn ▼ |
KC Professional | $820.00M ▲ | $800.00M ▼ | $770.00M ▼ | $0 ▼ |
Personal Care | $2.71Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Kimberly-Clark Corporation's financial evolution and strategic trajectory over the past five years.
Kimberly-Clark benefits from powerful global brands, entrenched shelf space, and a highly cash-generative, defensive business model. Profit margins have improved over time despite revenue volatility, reflecting pricing power and tight cost control. The company produces strong operating and free cash flow, has modestly reduced net debt, and continues to grow retained earnings. Its strategic focus on digital tools, smart professional products, and sustainability-aligned innovation further supports its long-standing competitive position.
The main concerns center on revenue declines in the most recent years, very high leverage relative to equity, and signs of possible underinvestment. Liquidity is adequate but not generous, relying heavily on ongoing cash inflows. The apparent elimination of R&D and sharp drop in capex in the latest year may indicate a tilt toward short-term margin support at the expense of long-term growth and product renewal, unless explained by one-off or classification factors. Competitive pressure from global peers and private labels, combined with input cost volatility and evolving sustainability demands, adds to the risk backdrop.
Looking ahead, Kimberly-Clark appears positioned as a stable, cash-rich, defensive consumer company with strong brands but facing a balancing act between protecting margins and reigniting growth. If management executes on its stated investment plans in advanced manufacturing, digital capabilities, and sustainable innovation, that could help support volumes and brand strength over time. Conversely, if revenue softness persists and reinvestment remains constrained, the company could see gradual pressure on its market share and pricing power, even while near-term profitability remains respectable. Overall, the trajectory leans on how effectively Kimberly-Clark can translate its strategic innovation ambitions into sustained top-line growth without overstraining an already leveraged balance sheet.
About Kimberly-Clark Corporation
https://www.kimberly-clark.comKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $4.08B ▼ | $958M ▲ | $499M ▲ | 12.23% ▲ | $1.5 ▲ | $685M ▼ |
| Q3-2025 | $4.13B ▼ | $855M ▼ | $446M ▼ | 10.79% ▼ | $1.34 ▼ | $833M ▲ |
| Q2-2025 | $4.16B ▼ | $864M ▼ | $509M ▼ | 12.23% ▲ | $1.53 ▼ | $802M ▼ |
| Q1-2025 | $4.84B ▼ | $964M ▼ | $567M ▲ | 11.71% ▲ | $1.71 ▲ | $976M ▲ |
| Q4-2024 | $4.93B | $1.13B | $447M | 9.07% | $1.34 | $760M |
What's going well?
Net income and earnings per share both improved this quarter, mainly due to a much lower tax bill. The company remains profitable and revenue is steady.
What's concerning?
Operating income and margins are falling as costs rise faster than sales. The improvement in profit is mostly from lower taxes, not better business performance.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $688M ▲ | $17.23B ▲ | $15.57B ▲ | $1.5B ▲ |
| Q3-2025 | $617M ▼ | $16.89B ▲ | $15.42B ▲ | $1.33B ▲ |
| Q2-2025 | $634M ▲ | $16.77B ▲ | $15.37B ▲ | $1.27B ▲ |
| Q1-2025 | $563M ▼ | $16.3B ▼ | $15.08B ▼ | $1.1B ▲ |
| Q4-2024 | $1.02B | $16.55B | $15.57B | $840M |
What's financially strong about this company?
KMB has a long record of profits, a solid base of real assets, and is managing inventory and receivables well. Debt is mostly long-term, giving them time to manage repayments.
What are the financial risks or weaknesses?
Liquidity is tight, with current assets not covering near-term bills. The company is highly leveraged, with much more debt than equity, leaving little margin for error if business slows.
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $510M ▲ | $972M ▲ | $-2.99B ▼ | $-141M ▼ | $71M ▲ | $575M ▼ |
| Q3-2025 | $454M ▼ | $708M ▼ | $312M ▲ | $1.18B ▲ | $-40M ▼ | $1.11B ▲ |
| Q2-2025 | $512M ▼ | $770M ▲ | $-193M ▼ | $-500M ▲ | $94M ▲ | $573M ▲ |
| Q1-2025 | $573M ▲ | $327M ▼ | $-119M ▲ | $-683M ▲ | $-458M ▼ | $123M ▼ |
| Q4-2024 | $452M | $817M | $-194M | $-686M | $-90M | $608M |
What's strong about this company's cash flow?
KMB consistently generates positive cash from its core business, with operating cash flow rising to $972 million. Dividends are well covered, and the company isn't dependent on outside funding.
What are the cash flow concerns?
Free cash flow dropped sharply from last quarter, partly due to less help from working capital and higher capital spending. The cash balance is only moderate, so big surprises could tighten things.
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Consumer Tissue | $1.60Bn ▲ | $1.50Bn ▼ | $1.54Bn ▲ | $1.52Bn ▼ |
KC Professional | $820.00M ▲ | $800.00M ▼ | $770.00M ▼ | $0 ▼ |
Personal Care | $2.71Bn ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Kimberly-Clark Corporation's financial evolution and strategic trajectory over the past five years.
Kimberly-Clark benefits from powerful global brands, entrenched shelf space, and a highly cash-generative, defensive business model. Profit margins have improved over time despite revenue volatility, reflecting pricing power and tight cost control. The company produces strong operating and free cash flow, has modestly reduced net debt, and continues to grow retained earnings. Its strategic focus on digital tools, smart professional products, and sustainability-aligned innovation further supports its long-standing competitive position.
The main concerns center on revenue declines in the most recent years, very high leverage relative to equity, and signs of possible underinvestment. Liquidity is adequate but not generous, relying heavily on ongoing cash inflows. The apparent elimination of R&D and sharp drop in capex in the latest year may indicate a tilt toward short-term margin support at the expense of long-term growth and product renewal, unless explained by one-off or classification factors. Competitive pressure from global peers and private labels, combined with input cost volatility and evolving sustainability demands, adds to the risk backdrop.
Looking ahead, Kimberly-Clark appears positioned as a stable, cash-rich, defensive consumer company with strong brands but facing a balancing act between protecting margins and reigniting growth. If management executes on its stated investment plans in advanced manufacturing, digital capabilities, and sustainable innovation, that could help support volumes and brand strength over time. Conversely, if revenue softness persists and reinvestment remains constrained, the company could see gradual pressure on its market share and pricing power, even while near-term profitability remains respectable. Overall, the trajectory leans on how effectively Kimberly-Clark can translate its strategic innovation ambitions into sustained top-line growth without overstraining an already leveraged balance sheet.

CEO
Michael D. Hsu
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2014-11-03 | Forward | 1043:1000 |
| 1997-04-03 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 795
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
UBS
Neutral
Citigroup
Sell
TD Cowen
Hold
Wells Fargo
Equal Weight
BNP Paribas Exane
Neutral
Argus Research
Buy
Grade Summary
Showing Top 6 of 12
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:40.85M
Value:$4.55B
BLACKROCK INC.
Shares:31.39M
Value:$3.5B
BLACKROCK, INC.
Shares:28.74M
Value:$3.2B
Summary
Showing Top 3 of 2,544

